We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$211M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$167M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$136M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$58.1M
5
KHC icon
Kraft Heinz
KHC
+$48.8M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$68.1M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$65.7M
3
RGC
Regal Entertainment Group
RGC
+$48.4M
4
EFG icon
iShares MSCI EAFE Growth ETF
EFG
+$36.9M
5
COL
Rockwell Collins
COL
+$34.9M

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTU icon
3026
Peabody Energy
BTU
$3B
$235K ﹤0.01%
+6,435
New +$256K
JHA
3027
DELISTED
Nuveen High Inc Dec 2018 Tgt Trm
JHA
$235K ﹤0.01%
23,976
+9,111
+61% +$89.9K
MZF
3028
DELISTED
Managed Duration Inv Grd Muni Fd
MZF
$235K ﹤0.01%
17,308
– –
BPMC
3029
DELISTED
Blueprint Medicines
BPMC
$234K ﹤0.01%
2,556
-448
-15% -$38.6K
FT
3030
Franklin Universal Trust
FT
$197M
$234K ﹤0.01%
34,640
-3,000
-8% -$20.7K
S
3031
DELISTED
Sprint Corporation
S
$234K ﹤0.01%
47,890
+29,745
+164% +$159K
ACHN
3032
DELISTED
Achillion Pharmaceuticals
ACHN
$233K ﹤0.01%
62,850
-5,600
-8% -$18.3K
FDIQ
3033
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$48.3M
$232K ﹤0.01%
+4,088
New +$237K
ABBV icon
3034
CALL
AbbVie
ABBV
$438B
$231K ﹤0.01%
122,900
-33,700
-22% -$3.7M
BRID icon
3035
Bridgford Foods
BRID
$57.8M
$231K ﹤0.01%
15,450
+5,150
+50% +$86.6K
HUBG icon
3036
HUB Group
HUBG
$2.9B
$231K ﹤0.01%
11,044
-13,272
-55% -$309K
EVH icon
3037
Evolent Health
EVH
$444M
$230K ﹤0.01%
16,173
+1,574
+11% +$22.5K
FRI icon
3038
First Trust S&P REIT Index Fund
FRI
$201M
$230K ﹤0.01%
10,787
+590
+6% +$12.7K
MVV icon
3039
ProShares Ultra MidCap400
MVV
$161M
$230K ﹤0.01%
5,781
+336
+6% +$13.9K
KND
3040
DELISTED
Kindred Healthcare
KND
$230K ﹤0.01%
+25,150
New +$233K
INDB icon
3041
Independent Bank
INDB
$3.97B
$229K ﹤0.01%
3,204
+67
+2% +$4.82K
PEJ icon
3042
Invesco Leisure and Entertainment ETF
PEJ
$306M
$229K ﹤0.01%
5,148
-230
-4% -$10.4K
EWK icon
3043
iShares MSCI Belgium ETF
EWK
$164M
$228K ﹤0.01%
10,662
+1,103
+12% +$24.3K
NWSA icon
3044
News Corp Class A
NWSA
$15.4B
$228K ﹤0.01%
14,457
+776
+6% +$12.8K
GME icon
3045
GameStop
GME
$8.43B
$227K ﹤0.01%
+72,092
New +$294K
URTH icon
3046
iShares MSCI World ETF
URTH
$8.34B
$227K ﹤0.01%
2,602
– –
PVLA
3047
Palvella Therapeutics
PVLA
$2.19B
$226K ﹤0.01%
414
+186
+82% +$115K
FEN
3048
DELISTED
First Trust Energy Income and Growth Fund
FEN
$226K ﹤0.01%
10,392
-1,402
-12% -$34.6K
DCOM
3049
DELISTED
Dime Community Bancshares
DCOM
$226K ﹤0.01%
12,270
– –
DTH icon
3050
WisdomTree International High Dividend Fund
DTH
$660M
$225K ﹤0.01%
+5,170
New +$232K
120 121
122
123 124

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.